EddingPharm Secures China NMPA Approval for Vascepa

Amarin Corporation plc, an innovative pharmaceutical firm, stated that its commercial partner in Mainland China (China), EddingPharm (Edding), has gained regulatory approval for Vascepa (icosapent ethyl) from the National Medical Products...

Abbott Drives Vertigo Understanding With 'Chakkar Ko Check Kar' campaign

Abbott, the global healthcare leader, launched its ‘Chakkar Ko Check Kar’ campaign in India to highlightanoften-overlooked balance disorder,vertigo, which affects close to 70 million people in India.Vertigo is a condition that can make people feel...

Antidote and Seqster Join Hands To Advance Patient Identification

Antidote Technologies, a digital health firm that focuses on patient engagement to advance recruitment for clinical trials, and SEQSTER PDM Inc., the leading patient-centric healthcare technology company, declared an agreement to improve patient...

Unlock The Future Of Beauty At Cosmetics Ingredients Expo: Innovation, Sustainability & Industry Expertise On Display

Get ready for the highly anticipated Cosmetics Ingredients Expo 2024, a premier event that will bring together the best minds and leading innovators in the cosmetics industry.

Ligand Pharma To Acquire APEIRON Biologics For USD 100 Million

Ligand Pharmaceuticals, a biopharmaceutical company, delcared that it has forayed into a definitive contract to acquire APEIRON Biologics AG, which holds royalty rights to QARZIBA® (dinutuximab beta) for the treatment of high-risk neuroblastoma...

US FDA Nods Biostar Pharma's IND application For Phase 2 Study

Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Biostar), a synthetic biology-driven biopharma firm focused on the creation and marketing of innovative oncology drugs, declared that the US FDA had approved...

Innovent Biologics and IASO Bio Join Hands For Cell Therapy

Innovative Biomedicals, Inc, a top notch biopharmaceutical organization that creates, manufactures and market great medications for the treatment of oncology, immune system, cardiovascular and metabolic, ophthalmology and other significant...

Roche Secures US FDA Nod For Vabysmo Prefilled Syringe

Roche, a leading pharmaceutical firm, declared the United States Food and Drug Administration (US FDA) has sanctioned the Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of neovascular or ‘wet’ age-related...

Genexine To Merge with EPD Biotherapeutics For Drug Development

Genexine, a publicly traded clinical-stage Korean biopharmaceutical company dedicated to the discovery and development of novel biologics for the treatment of serious unmet medical needs, has announced a merger with EPD Biotherapeutics (EPD Bio)...

Pulsus Group to Funnel Rs 300 crore in Pharma Healthcare IT hub

Pulsus Group intends to establish an AI-based pharma healthcare IT cluster in Ameenpur, Sangareddy district, Telangana, at a cost of Rs 300 crore with the potential to create approximately 50,000 jobs. Pulsus Group CEO and...

© 2024 India Pharma Outlook. All Rights Reserved.